Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Short Interest Update

Key Points

• Baird Medical Investment Holdings Limited (NASDAQ:BDMD) experienced a significant increase in short interest, rising 52.8% to 105,900 shares as of September 30th.
• Institutional ownership of BDMD is approximately 19.78%, with notable investments from firms like XTX Topco Ltd and Geode Capital Management LLC.
• Wall Street analysts have a predominantly negative outlook on the stock, with a consensus rating of "Sell," following downgrades from several research firms.

Baird Medical Investment Holdings Limited (NASDAQ:BDMD - Get Free Report) saw a large growth in short interest in the month of September. As of September 30th, there was short interest totaling 105,900 shares, a growth of 52.8% from the September 15th total of 69,300 shares. Approximately 0.9% of the company's stock are short sold. Based on an average daily volume of 300,900 shares, the short-interest ratio is currently 0.4 days. Based on an average daily volume of 300,900 shares, the short-interest ratio is currently 0.4 days. Approximately 0.9% of the company's stock are short sold.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of BDMD. XTX Topco Ltd bought a new position in Baird Medical Investment in the first quarter worth $111,000. Geode Capital Management LLC lifted its position in Baird Medical Investment by 59.7% in the second quarter. Geode Capital Management LLC now owns 25,442 shares of the company's stock worth $93,000 after purchasing an additional 9,511 shares during the period. Finally, Jane Street Group LLC bought a new position in shares of Baird Medical Investment during the second quarter valued at $142,000. 19.78% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on BDMD. Weiss Ratings restated a "sell (d+)" rating on shares of Baird Medical Investment in a report on Wednesday, October 8th. Wall Street Zen cut Baird Medical Investment from a "hold" rating to a "sell" rating in a research report on Monday, July 14th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Baird Medical Investment has an average rating of "Sell".

Baird Medical Investment Stock Down 1.9%

Shares of BDMD stock opened at $1.59 on Wednesday. Baird Medical Investment has a one year low of $1.05 and a one year high of $12.50. The stock has a fifty day moving average price of $2.19 and a 200 day moving average price of $3.65.

Baird Medical Investment Company Profile

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.